Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfister

Showing results (311-320 of 754) with videos related to

Pageof 76
Sort By:
Acta Neuropathologica Communications|April 9, 2015
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastomaJonas Ecker, Ina Oehme, Ralph Mazitschek, et al.
Neuro-Oncology Advances|May 5, 2021
ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastomaAishah Nasir, Alice Cardall, Ramadhan T Othman, et al.
Acta Neuropathologica Communications|November 7, 2018
Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial locationDavid Castel, Cathy Philippe, Thomas Kergrohen, et al.
Nature Reviews. Cancer|July 14, 2019
Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumoursDavid T W Jones, Ana Banito, Thomas G P Grünewald, et al.
Acta Neuropathologica|March 4, 2019
Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profilesAndrey Korshunov, Felix Sahm, Konstantin Okonechnikov, et al.
Acta Neuropathologica|September 7, 2018
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaDamian Stichel, Azadeh Ebrahimi, David Reuss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratificationAndrey Korshunov, Marc Remke, Wiebke Werft, et al.
Neuro-Oncology|November 9, 2013
Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomasRatika Kunder, Rakesh Jalali, Epari Sridhar, et al.
Journal of Neuro-Oncology|November 24, 2023
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflowFlorian Selt, Ahmed El Damaty, Martin U Schuhmann, et al.
JNCI Cancer Spectrum|January 28, 2025
Cancer risk in carriers of TP53 germline variants grouped into different functional categoriesLucas John Müntnich, Christina M Dutzmann, Anika Großhennig, et al.
Pageof 76

Showing results (311-320 of 754) with videos related to

Sort By:
Pageof 76
Acta Neuropathologica Communications|April 9, 2015
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastomaJonas Ecker, Ina Oehme, Ralph Mazitschek, et al.
Neuro-Oncology Advances|May 5, 2021
ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastomaAishah Nasir, Alice Cardall, Ramadhan T Othman, et al.
Acta Neuropathologica Communications|November 7, 2018
Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial locationDavid Castel, Cathy Philippe, Thomas Kergrohen, et al.
Nature Reviews. Cancer|July 14, 2019
Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumoursDavid T W Jones, Ana Banito, Thomas G P Grünewald, et al.
Acta Neuropathologica|March 4, 2019
Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profilesAndrey Korshunov, Felix Sahm, Konstantin Okonechnikov, et al.
Acta Neuropathologica|September 7, 2018
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaDamian Stichel, Azadeh Ebrahimi, David Reuss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratificationAndrey Korshunov, Marc Remke, Wiebke Werft, et al.
Neuro-Oncology|November 9, 2013
Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomasRatika Kunder, Rakesh Jalali, Epari Sridhar, et al.
Journal of Neuro-Oncology|November 24, 2023
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflowFlorian Selt, Ahmed El Damaty, Martin U Schuhmann, et al.
JNCI Cancer Spectrum|January 28, 2025
Cancer risk in carriers of TP53 germline variants grouped into different functional categoriesLucas John Müntnich, Christina M Dutzmann, Anika Großhennig, et al.
Pageof 76